{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/realizing-potential-decentralized-clinical-trials-oncology#webpage",
"url": "https://www.fortrea.com/insights/realizing-potential-decentralized-clinical-trials-oncology",
"name": "Realizing the potential of decentralized clinical trials in oncology",
"description": "This Fortrea infosheet explores the growing role of decentralized clinical trials in oncology and how decentralized approaches can improve patient participation, operational flexibility, and trial accessibility across oncology research programs. The content focuses on patient recruitment challenges, patient-centric oncology trial delivery, remote data collection, digital health solutions, and decentralized clinical trial components designed to reduce participation burden for oncology patients and caregivers. The infosheet highlights how oncology clinical trials increasingly require flexible approaches that support real-time data review, patient retention, remote monitoring, and improved access to specialized oncology studies. Fortrea outlines how decentralized trial strategies and digital health technologies can help support oncology clinical trial execution while improving patient experience and expanding participation opportunities. By integrating decentralized clinical trial approaches with oncology operational planning and patient-focused delivery strategies, the infosheet provides insights into evolving models for decentralized clinical trials in oncology."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Realizing the potential of decentralized clinical trials in oncology",
"item": "https://www.fortrea.com/insights/realizing-potential-decentralized-clinical-trials-oncology"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/realizing-potential-decentralized-clinical-trials-oncology#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/realizing-potential-decentralized-clinical-trials-oncology#webpage"
},
"headline": "Realizing the Potential of Decentralized Clinical Trials in Oncology | Fortrea Infosheet",
"description": "This Fortrea infosheet explores the growing role of decentralized clinical trials in oncology and how decentralized approaches can improve patient participation, operational flexibility, and trial accessibility across oncology research programs. The content focuses on patient recruitment challenges, patient-centric oncology trial delivery, remote data collection, digital health solutions, and decentralized clinical trial components designed to reduce participation burden for oncology patients and caregivers. The infosheet highlights how oncology clinical trials increasingly require flexible approaches that support real-time data review, patient retention, remote monitoring, and improved access to specialized oncology studies. Fortrea outlines how decentralized trial strategies and digital health technologies can help support oncology clinical trial execution while improving patient experience and expanding participation opportunities. By integrating decentralized clinical trial approaches with oncology operational planning and patient-focused delivery strategies, the infosheet provides insights into evolving models for decentralized clinical trials in oncology.",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-20",
"dateModified": "2025-03-20",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-03/realizing-the-potential-of-decentralized-clinical-trials-in-oncology.pdf",
"encodingFormat": "application/pdf"
}
}
]
}